|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 123.60 GBX | -0.80% |
|
+0.65% | -1.12% |
| Feb. 20 | Inflation's Reality Check |  |
| Feb. 20 | PureTech says its pulmonary fibrosis drug granted orphan designation | AN |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Neutral |
| Resistance | 129 | 141.2 | 146.4 |
| Spread/Res. | -4.19% | -12.46% | -15.57% |
| Spread/Supp. | +0.65% | +16.17% | +8.61% |
| Support | 122.8 | 106.4 | 113.8 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- PRTC Stock
- Charts PureTech Health plc
Select your edition
All financial news and data tailored to specific country editions
